The negative immunoregulatory effects of serotonin (5-HT) moduline, an endogenous 5-HT1B receptor antagonist with anti-anxiety properties

被引:9
|
作者
Maes, M
Kenis, G
Bosmans, E
机构
[1] Univ Hosp Maastricht, Dept Psychiat, NL-6202 AZ Maastricht, Netherlands
[2] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA
[3] Clin Res Ctr Mental Hlth, Limburg, Belgium
关键词
serotonin; moduline; cytokine; interferon; tumor necrosis factor; cAMP;
D O I
10.1006/cyto.2002.1053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Serotonin (5-HT) has negative immunoregulatory effects by reducing the interferon-gamma (IFNgamma)/interleukin-10 (IL-10) production ratio by stimulated immune cells. Leukocytes have functional 5-HT1B receptors. 5-HT moduline, an endogenous 5-HT1B receptor antagonist, may antagonize the 5-HT1B agonist-induced proliferation of immune cells. Aims: To examine the effects of 5-HT moduline on the stimulated production of IFNgamma, tumor necrosis factor alpha (TNFalpha) and IL-10. Results: 5-HT moduline, 10(-6) M and 10(-5) M, significantly reduced the production of IFNgamma and the IFNgamma/IL-10 ratio. 5-HT moduline 10(-5)M significantly reduced the production of TNFa. The combination of 5-HT, 15 mug/mL, with 5-HT moduline, 10(-6) M and 10(-5) M, further decreases the IFNgamma/IL-10 production ratio. Interpretation: 5-HT moduline has negative immunoregulatory effects.
引用
收藏
页码:308 / 311
页数:4
相关论文
共 50 条
  • [31] Serotonin (5-HT) hyperpolarized orexin neurons via a 5-HT 1A receptor
    Muraki, Y
    Yamanaka, A
    Tsujino, N
    Hirashima, N
    Sakuri, T
    Goto, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 76P - 76P
  • [32] Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT1A or 5-HT1B receptor knockout mice
    Ase, AR
    Reader, TA
    Hen, R
    Riad, M
    Descarries, L
    JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) : 2415 - 2426
  • [33] Trazodone Acts as a Serotonin (5-HT) Reuptake Inhibitor and 5-HT1A Receptor Agonist on the 5-HT System
    Ghanbari, Ramez
    El Mansari, Mostafa
    Blier, Pierre
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 242S - 242S
  • [34] SB-272183, a selective 5-HT1A, 5-HT1B and 5-HT1D receptor antagonist.
    Roberts, C
    Watson, J
    Scott, C
    Collin, L
    Harries, MH
    Wyman, P
    Gaster, L
    Price, GW
    Midlemiss, DN
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U76 - U76
  • [35] THE HUMAN 5-HT1B RECEPTOR
    JIN, H
    OKSENBERG, D
    ASKENAZI, A
    PEROUTKA, SJ
    MENGOD, G
    ROZMAHEL, R
    YANG, Y
    PALACIOS, JM
    ODOWD, BF
    FASEB JOURNAL, 1992, 6 (04): : A1554 - A1554
  • [36] 5-HT1B receptor antagonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (04) : 189 - 189
  • [37] Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter
    Fabre, V
    Beaufour, C
    Evrard, A
    Rioux, A
    Hanoun, N
    Lesch, KP
    Murphy, DL
    Lanfumey, L
    Hamon, M
    Martres, MP
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (07) : 2299 - 2310
  • [38] Effects of SL 65.0472, a novel 5-HT receptor antagonist, on 5-HT receptor mediated vascular contraction
    Galzin, AM
    Delahaye, M
    Hoornaert, C
    McCort, G
    O'Connor, SE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 404 (03) : 361 - 368
  • [39] Hypothermia and the 5-HT syndrome induced by CGS 12066B independently of 5-HT1B receptor activation
    Bjorvatn, B
    Neckelmann, D
    Bjorkum, AA
    Ursin, R
    BEHAVIOURAL PHARMACOLOGY, 1996, 7 (05): : 462 - 469
  • [40] Interactions of GR127935, a 5-HT1B/D receptor ligand, with functional 5-HT receptors
    DeVries, P
    Apaydin, S
    Villalon, CM
    Heiligers, JPC
    Saxena, PR
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P67 - P67